Jacopo Chiaro

719 total citations
21 papers, 411 citations indexed

About

Jacopo Chiaro is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jacopo Chiaro has authored 21 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Jacopo Chiaro's work include Immunotherapy and Immune Responses (15 papers), CAR-T cell therapy research (9 papers) and vaccines and immunoinformatics approaches (8 papers). Jacopo Chiaro is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), CAR-T cell therapy research (9 papers) and vaccines and immunoinformatics approaches (8 papers). Jacopo Chiaro collaborates with scholars based in Finland, Italy and Netherlands. Jacopo Chiaro's co-authors include Vincenzo Cerullo, Sara Feola, Beatriz Martins, Manlio Fusciello, Erkko Ylösmäki, Firas Hamdan, Cristian Capasso, Flavia Fontana, Jouni Hirvonen and Karita Peltonen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Jacopo Chiaro

21 papers receiving 406 citations

Peers

Jacopo Chiaro

IMMUN

ONCOL

GENET

João Paulo Portela Catani Belgium

Angela Q. Zhang United States

Daoyuan Xie China

Pranali Ravikumar United States

Djenet Bousbaine United States

Nadine Kasnitz Germany

Marcel Kuiper United Kingdom

Yanhong Chu China

Megha Shettigar United States

Khushbu Bhatt United States

João Paulo Portela Catani Belgium

Jacopo Chiaro

211 ×1.0

370 ×1.9

IMMUN

251 ×1.3

ONCOL

66 ×0.6

57 ×0.6

GENET

Citations per year, relative to Jacopo Chiaro Jacopo Chiaro (= 1×) peers João Paulo Portela Catani

Countries citing papers authored by Jacopo Chiaro

Since Specialization

Citations

This map shows the geographic impact of Jacopo Chiaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacopo Chiaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacopo Chiaro more than expected).

Fields of papers citing papers by Jacopo Chiaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacopo Chiaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacopo Chiaro. The network helps show where Jacopo Chiaro may publish in the future.

Co-authorship network of co-authors of Jacopo Chiaro

This figure shows the co-authorship network connecting the top 25 collaborators of Jacopo Chiaro. A scholar is included among the top collaborators of Jacopo Chiaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacopo Chiaro. Jacopo Chiaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiaro, Jacopo, Karita Peltonen, Kadri Õunap, et al.. (2025). Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates. npj Vaccines. 10(1). 195–195. 1 indexed citations

Garofalo, Mariangela, Monika Staniszewska, Jacopo Chiaro, et al.. (2024). Cancer vaccines: an update on recent achievements and prospects for cancer therapy. Clinical and Experimental Medicine. 25(1). 24–24. 4 indexed citations

Feola, Sara, Firas Hamdan, Salvatore Russo, et al.. (2024). Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors. Journal for ImmunoTherapy of Cancer. 12(3). e008342–e008342. 7 indexed citations

Russo, Salvatore, Sara Feola, Jacopo Chiaro, et al.. (2024). Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy. SHILAP Revista de lepidopterología. 32(1). 200766–200766. 2 indexed citations

Matos, Ana I., Flavia Fontana, Jacopo Chiaro, et al.. (2024). Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer. Advanced Healthcare Materials. 14(5). e2401523–e2401523. 8 indexed citations

Feola, Sara, Jacopo Chiaro, & Vincenzo Cerullo. (2023). Integrating immunopeptidome analysis for the design and development of cancer vaccines. Seminars in Immunology. 67. 101750–101750. 14 indexed citations

Hamdan, Firas, Salvatore Russo, Manlio Fusciello, et al.. (2023). Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 inhibitors using oncolytic adenoviruses. Molecular Therapy — Oncolytics. 28. 264–276. 2 indexed citations

Fusciello, Manlio, Erkko Ylösmäki, Sara Feola, et al.. (2022). A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella. Molecular Therapy — Oncolytics. 25. 137–145. 3 indexed citations

Feola, Sara, Salvatore Russo, Beatriz Martins, et al.. (2022). Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine. Frontiers in Immunology. 13. 826164–826164. 14 indexed citations

10.

Feola, Sara, Jacopo Chiaro, Beatriz Martins, et al.. (2022). A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines. eLife. 11. 26 indexed citations

11.

Ylösmäki, Erkko, Manlio Fusciello, Beatriz Martins, et al.. (2021). Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin. Journal for ImmunoTherapy of Cancer. 9(7). e002707–e002707. 22 indexed citations

12.

Peltonen, Karita, Sara Feola, Husen M. Umer, et al.. (2021). Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy. Cancers. 13(14). 3408–3408. 17 indexed citations

13.

Chiaro, Jacopo, Thomas Whalley, Cristian Capasso, et al.. (2021). Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma. Cancer Immunology Research. 9(8). 981–993. 25 indexed citations

14.

Chiaro, Jacopo, Vincenzo Cerullo, Kirsi Savijoki, et al.. (2021). Surfaceome and Exoproteome Dynamics in Dual-Species Pseudomonas aeruginosa and Staphylococcus aureus Biofilms. Frontiers in Microbiology. 12. 672975–672975. 12 indexed citations

15.

Hamdan, Firas, Beatriz Martins, Sara Feola, et al.. (2021). GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses. Molecular Therapy — Methods & Clinical Development. 20. 625–634. 8 indexed citations

16.

Tähtinen, Siri, Sara Feola, Cristian Capasso, et al.. (2020). Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy. Cancer Research. 80(12). 2575–2585. 40 indexed citations

17.

Fontana, Flavia, Alexandra Correia, Jacopo Chiaro, et al.. (2020). Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions. Advanced Healthcare Materials. 9(17). e2000529–e2000529. 26 indexed citations

18.

Feola, Sara, Jacopo Chiaro, Beatriz Martins, & Vincenzo Cerullo. (2020). Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process. Cancers. 12(6). 1660–1660. 42 indexed citations

19.

Fontana, Flavia, Manlio Fusciello, Christianne Groeneveldt, et al.. (2019). Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor. ACS Nano. 13(6). 6477–6490. 40 indexed citations

20.

Fusciello, Manlio, Flavia Fontana, Siri Tähtinen, et al.. (2019). Artificially cloaked viral nanovaccine for cancer immunotherapy. Nature Communications. 10(1). 5747–5747. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact